Closing the Gap Between Hope and Cancer Cures

  • by: |
  • 12/18/2014
We have the tools to speed up development of new innovative medicines.  We just need the will.


December 18, 2014, 02:00 pm
Closing the gap between testing and treatment
The Hill
By John Morrissey

I have just returned from San Francisco and a meeting of more than 20-thousand blood cancer experts at a global hematology conference. I was there as part of  a new mission to rapidly-but-responsibly turn the data from these medical meetings into treatments.

A new alliance CLOSING-THE-GAP-NOW held a historic first conference at the University of Minnesota in mid-November.  Our goal is to streamline medical oversight. I know it can be done.  Under Presidents Nixon and Ford I worked to replace rules that delayed and discouraged advances in transportation.

ADVERTISEMENT
We are ready to the same for modern medicine.  It is a moral imperative.  
Consider. Today when a patient is prescribed a so-called new cancer treatment,  it is actually the product of testing that left the laboratory as much as ten years before. That delay, the years and expense of testing, is the force driving up the costs of new therapies while denying them to patients. 

The result? Tragic stories like the recent, very public case of Brittany Maynard. Diagnosed with a brain tumor and given but a few months to live, she raised the issue of the right to die. Her story really should have us thinking about what patients need  to survive.

I know first hand how these lies of omission can deny hope and atrophy will to live.

I received the message that nothing can help in March 2009 when my wife contracted pancreatic cancer. Six weeks after I lost my wife, I heard that same message  in October 2009 when my daughter was diagnosed with brain cancer.

The problem is, what we were told was just not the case. 

In fact, there were a number of promising mainstream medical treatments in various stages of development. I found them for my family.  Those innovative treatments gave us a little more time together as a family, and time is precious when it is running out.

How can we offer these same opportunities to every cancer patient?

Let’s understand that the current system is a product of the sixties.  But there could be a better, faster and safer path.

Let’s harness the real power of new science, of big data, of the specificity of genome sequencing.  Let’s re-imagine a review process in which each patient would get the best option and the most advanced care. Then, using computing tools with Google-like power we can capture and share all the data from their experiences. Every patient could in-effect be part of a huge virtual clinical trial while getting the best personal care.

A deluge of new information could begin to be available in ten weeks instead of ten years. Patients would not be kept waiting when they simply have no time to wait. 

Thinking of tragic stories like Brittany Maynard’s,  it’s long past time to appreciate the value of medical innovation and how we can use it to value each and every human life by updating the procedures and regulations that are supposed to enhance care, not interfere. 

Morrissey is chair of the Scientific Advisory Board at the Richard M Schulze Family Foundation.
CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog